Orphan designation: Doxorubicin,Liposomal,Pegylated Treatment of soft-tissue sarcoma, 22/05/2025 Positive | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 25 June 2025 - 9:18

Orphan designation: Doxorubicin,Liposomal,Pegylated Treatment of soft-tissue sarcoma, 22/05/2025 Positive

Link:

https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu-3-25-3056

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters